• Jazz Pharmaceuticals average return on tangible equity for 2024 was -14.48, a 631.31% increase from 2023.
• Jazz Pharmaceuticals average return on tangible equity for 2023 was -1.98, a 152.8% increase from 2022.
• Jazz Pharmaceuticals average return on tangible equity for 2022 was 3.75, a 90.65% decline from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.